GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (XSWX:QGEN) » Definitions » Shiller PE Ratio

Qiagen NV (XSWX:QGEN) Shiller PE Ratio : (As of May. 25, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Qiagen NV Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Qiagen NV Shiller PE Ratio Historical Data

The historical data trend for Qiagen NV's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Shiller PE Ratio Chart

Qiagen NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.61 96.85 75.31 53.93 41.51

Qiagen NV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.43 44.09 38.82 41.51 38.41

Competitive Comparison of Qiagen NV's Shiller PE Ratio

For the Diagnostics & Research subindustry, Qiagen NV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen NV's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Shiller PE Ratio falls into.



Qiagen NV Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Qiagen NV's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Qiagen NV's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/128.5800*128.5800
=0.000

Current CPI (Mar. 2024) = 128.5800.

Qiagen NV Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.130 99.240 0.168
201409 0.136 99.960 0.175
201412 0.111 99.050 0.144
201503 0.081 99.750 0.104
201506 0.106 100.230 0.136
201509 0.141 100.500 0.180
201512 0.207 99.730 0.267
201603 0.069 100.310 0.088
201606 0.087 100.260 0.112
201609 0.146 100.570 0.187
201612 0.039 100.710 0.050
201703 0.078 101.440 0.099
201706 0.058 101.370 0.074
201709 0.202 102.030 0.255
201712 -0.178 101.970 -0.224
201803 0.133 102.470 0.167
201806 0.158 103.100 0.197
201809 0.252 103.950 0.312
201812 0.258 103.970 0.319
201903 0.130 105.370 0.159
201906 0.188 105.840 0.228
201909 -0.703 106.700 -0.847
201912 0.187 106.800 0.225
202003 0.163 106.850 0.196
202006 0.361 107.510 0.432
202009 0.064 107.880 0.076
202012 0.808 107.850 0.963
202103 0.000 108.870 0.000
202106 0.000 109.670 0.000
202109 0.000 110.790 0.000
202112 0.000 114.010 0.000
202203 0.000 119.460 0.000
202206 0.000 119.050 0.000
202209 0.000 126.890 0.000
202212 0.000 124.940 0.000
202303 0.000 124.720 0.000
202306 0.000 125.830 0.000
202309 0.000 127.160 0.000
202312 0.000 126.450 0.000
202403 0.000 128.580 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Qiagen NV  (XSWX:QGEN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Qiagen NV Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen NV (XSWX:QGEN) Business Description

Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).